INS and Hypoglycemia: In one study, the use of a fast-acting analogue (FIASP) administered at mealtime or post-meal, to cover a standardized liquid meal, compared with pre-meal rapid insulin analogues, led to better HbA1c results without increasing hypoglycemia [24].